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 Summary 
 An initial feasibility study of options to treat the uranium plume at the 300-FF-5 Operable Unit 
considered hydraulic containment, slurry wall containment, and groundwater extraction as potential 
remedial action technologies.  None were selected for interim action, and reduction of contamination 
levels by natural processes was considered a viable alternative while source removal actions continued.  
Subsequent planning for a Phase III feasibility study focused on methods that would reduce the 
concentration of uranium in the aquifer, including multiple methods to immobilize uranium using 
chemical-based technologies.  Based on an initial technology screening, the polyphosphate technology 
was identified as the best candidate for further evaluation and selected for treatability testing. 
 The overall objective of the polyphosphate treatability test is to evaluate the efficacy of using 
polyphosphate injections to treat uranium contaminated groundwater in situ.  The objective of the work 
elements included in this site characterization plan is to collect site-specific characterization data that will 
be needed to design and implement a field-scale demonstration of the technology. 
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 1.0 Introduction 
 This site characterization plan covers work elements associated with site-specific characterization of 
the polyphosphate treatability test site.  Polyphosphate treatment shows promise for reducing the 
concentration of dissolved uranium in a plume that has persisted beneath the 300 Area for some time.  
The polyphosphate technology was selected for further testing during the 300-FF-5 Phase III Feasibility 
Study technology screening process.  An initial feasibility study (DOE 1995) for the 300-FF-5 uranium 
plume considered hydraulic containment, slurry wall containment, and groundwater extraction as 
potential remedial action technologies.  None were selected for interim action, and reduction of 
contamination levels by natural processes was considered a viable alternative while source removal 
actions continued.   
 Subsequent planning for a Phase III feasibility study focused on methods that would reduce the 
concentration of uranium in the aquifer, including multiple methods to immobilize uranium using 
chemical-based technologies.  Based on this initial technology screening, the polyphosphate technology 
was identified as the best candidate for further evaluation and selected for treatability testing.  The 
objective of the polyphosphate treatability test is to evaluate the efficacy of using polyphosphate 
injections to reduce uranium concentrations in groundwater to meet drinking water standards (30 ug/L) in 
situ.  The work elements described in this site characterization plan pertain to the collection of site-
specific characterization data that will be needed to design and implement a field-scale demonstration of 
the technology. 
 Data collected during the 300-FF-5 Limited Field Investigation (LFI) are being used to refine the 
hydrogeologic and geochemical conceptual model for the uranium plume that is the target of this 
treatability test.  Information developed under several research investigations into the geochemistry of 
uranium in the 300 Area (Serne et al. 2002; Zachara et al. 2005) has also contributed significantly to 
refining the conceptual site model for uranium contamination.  These results have been used to select an 
appropriate site for a field-scale demonstration of the polyphosphate treatment technology.  Well 399-1-
23, which was installed as part of the LFI, has been identified as the preferred location for a field-scale 
demonstration of the technology.  The remaining sections of this plan are written based on this 
assumption; if an alternate site is selected due to logistical or regulatory concerns, a characterization plan 
addendum will be issued documenting any variances.  During this characterization effort, monitoring 
wells will be installed in the vicinity of the selected injection well.  It is anticipated that up to six 
monitoring wells will be installed within the radial extent of the initial treatment zone, and an additional 
two to three monitoring wells will be installed to monitor downgradient transport of the polyphosphate 
amendment. 
 Following installation of the monitoring well network, several hydrogeologic characterization 
methods will be used to obtain additional site-specific information.  Planned activities include (1) site 
setup, (2) collection of baseline groundwater chemistry samples, (3) hydraulic testing to obtain formation 
hydraulic properties, (4) electromagnetic borehole flowmeter (EBF) testing to assess the vertical 
distribution of horizontal hydraulic conductivity (i.e., vertical heterogeneities), and (5) a conservative 
tracer injection test.  The tracer test will be used to further evaluate formation heterogeneities, to assess 
the downgradient transport of the tracer plume (i.e., aquifer transport properties), to refine the 
polyphosphate injection design, and to test operational procedures. 
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 2.0 Background 
 This section provides background information on the 300 Area uranium plume and the evolution of 
activities that will ultimately lead to a remedial action decision.  In 1996, a record of decision (EPA 1996) 
identified the following interim actions for remediation of the uranium contaminant plume beneath the 
site: 
• Continued groundwater monitoring to determine how contaminant conditions may change with time. 
• Institutional controls to limit the use of groundwater. 
 The interim action results have determined that uranium concentrations in the groundwater plume 
have been generally declining, but still persist at concentrations above the drinking water standard 
(remediation goal).  Therefore, re-evaluation of the remedy for uranium contamination is necessary 
because the rate of decrease in uranium concentrations is significantly different than the rate of decrease 
expected and used as a basis for the remedy selection in the current record of decision. 
2.1 300 Area Uranium Plume 
 A groundwater plume containing uranium from past-practice discharges of liquid waste associated 
with nuclear fuel fabrication activities has persisted beneath the Hanford Site 300 Area for many years.  
The persistence of this plume is enigmatic for several reasons, including (1) discharges containing 
uranium-bearing effluent to ground disposal sites ended in the mid-1980s; (2) contaminated soil asso-
ciated with these waste sites was removed during the 1990s, with backfilling complete by early 2004; 
and (3) the aquifer is comprised of highly transmissive fluvial sediment, suggesting rapid movement of 
groundwater.  Also, a water supply well located within the plume has been in operation since 1980, with 
no observable effect on the plume.  The current conceptual site model assumes that re-supply of the 
plume is occurring, with continuing release from the vadose zone beneath waste sites, the capillary fringe 
zone, and possibly from aquifer solids, as source candidates (Peterson et al. 2005). 
 A remedial investigation conducted in the early 1990s, along with an expedited response action to 
remove contaminated soil from the most recently used disposal site, led to a 1996 record of decision (EPA 
1996) for interim remedial action that involved continued groundwater monitoring and institution controls 
on the use of groundwater.  Characterization of natural features and processes that would lead to attenu-
ation of the contamination is part of the interim action, which continues.  A computer simulation of the 
plume during the initial remedial investigation led to a prediction that concentrations would decrease to 
the proposed drinking water standard (20 μg/L in 1993) in 3 to 10 years from 1993, assuming no 
re-supply of uranium to the plume (DOE 1995).  This predicted response has not been observed in 
monitoring well trend data. 
 Maximum concentrations in the plume are currently less than 250 μg/L, with mode values ranging 
from 30 to 90 μg/L.  The plume (>30 μg/L) currently covers an area of ~0.4 km2 (0.15 mi2).  Assuming a 
representative thickness of the contaminated layer of 3.3 m (10.8 ft) and 27% porosity, the volume of 
contaminated groundwater is ~350,000 m3 (460,000 yd3) and the mass of dissolved uranium is ~20 kg 
(Peterson et al. 2005).  The length of Columbia River shoreline impacted is ~1,500 m (4,900 ft).  Uranium 
removal via a water supply well for the 331 Life Sciences Building is ~21 kg/yr, based on monitoring 
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 data.  Detailed estimates for the net flux of uranium to the river are not yet available, but are expected 
soon as a product of computer simulation efforts.  Note:  Although groundwater flow rates are high, net 
discharge to the Columbia River is tempered by bank storage effects created by river stage fluctuations 
(Waichler and Yabusaki 2005). 
 Principal investigations leading to the current conceptual site model for this plume include early work 
to describe the hydrogeology and groundwater contamination of the 300 Area (Lindberg and Bond 1979); 
detailed investigations to support RCRA requirements at the 300 Area Process Trenches (Schalla et al. 
1988); and the initial remedial investigation under CERCLA for the 300-FF-5 groundwater operable unit 
(DOE 1995).  More recently, detailed geochemical research involving uranium in 300 Area sediment has 
been conducted to support decisions associated with cleanup of surface waste sites (Serne et al. 2002) and 
the renewed feasibility study of potential remedial action alternatives for the plume (Zachara et al. 2005).  
The latter investigations, which were conducted under the DOE’s science and technology research 
programs, included sampling the vadose zone beneath two major liquid waste disposal sites located near 
the proposed treatability test site (well 399-1-23).  Samples from vertical profiles that spanned the base of 
the disposal site excavations down to the water table were collected, and subjected to intensive laboratory 
investigations to determine the geochemical and mobility characteristics of residual uranium in the lower 
vadose zone. 
2.2 300-FF-5 Limited Field Investigation 
  An LFI is being conducted as part of the Phase III Feasibility Study to reduce uncertainties in two 
aspects of the conceptual model for the uranium plume:  (1) the vertical distribution of uranium in the 
vadose zone and uppermost aquifer at representative sites, with special emphasis on the interface between 
unsaturated and saturated conditions (i.e., the capillary fringe zone) and geochemical characteristics that 
influence the mobility of uranium, and (2) the vertical and lateral distribution of uranium throughout the 
mapped plume area where drinking water standards are exceeded (DOE 2006). 
 The first phase of the LFI characterization is complete.  This included collecting continuous core 
samples and depth-discrete groundwater samples, and conducting aquifer tests from four sites that are 
representative of various combinations of proximity to waste sites and to the river, and in various 
hydrogeologic environments (Figure 1).  The entire LFI area of interest is defined by the extent of the 
uranium plume, i.e., the area where concentrations are above natural background levels (i.e., above 
~10 μg/L).  The extent and general shape of this area has not changed appreciably for many years 
(Peterson et al. 2005).  The distribution pattern of the higher concentrations within this area varies 
significantly with time and is thought to be a consequence of liquid effluent disposal activities, source 
excavation activities, fluctuations in water-table elevations, and plume migration.  Results from drilling 
and characterization in the four new wells indicate that the highest groundwater and vadose concentration 
of uranium is in the two downgradient wells 399-1-23 (C5000) and 399-3-18 (C4999).  Results from 
these wells are being compiled and interpreted and will be available in forthcoming reports.  All the new 
wells have been completed with 15-cm- (6-in.-) diameter casing and screens to support treatability 
testing; first routine sampling of these wells occurred in July 2006. 
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Figure 1.  LFI Characterization Well Location Map 
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 2.3 Public Involvement in 300 Area Groundwater Decisions  
Over the past 4 years, several public workshops have been held to discuss remedial action alternatives and 
future land use options for the Hanford 300 Area: 
• June 2002 and May 2003:  U.S. Environmental Protection Agency (EPA)-sponsored stakeholder 
workshops to discuss remedial action alternatives for the 300 Area uranium plume. 
• May 2004:  U.S. Department of Energy (DOE) Science and Technology Program open meeting with 
contractors and the public – Conceptual Model Development and Reactive Transport Modeling for 
the 300 Area Uranium Plume. 
• August 2004:  DOE Headquarters review and discussion of 300 Area uranium plume – Monitoring 
Optimization Technical Assistance Workshop. 
• May 2005:  DOE-sponsored stakeholder workshop to receive public input on remedial actions and 
future land use for the 300 Area – 300 Area End States Public Workshop. 
• October 2005:  DOE-sponsored stakeholder involvement workshop – 300-FF-5 Workshop and Tour:  
Progress of the Limited Field Investigation Supporting the Phase III Feasibility Study. 
 
 Input received from these workshops supports investigating remedial action technologies that are 
designed to reduce the concentrations of uranium in groundwater beneath the 300 Area such that the 
aquifer can be restored to its maximum beneficial use, i.e., as a resource for drinking water.  Reducing 
concentrations in the aquifer will also reduce any potential risk to ecological receptors in the Columbia 
River. 
2.4 Polyphosphate Technology Description 
 The use of soluble long-chain polyphosphate materials has been demonstrated to delay the precipi-
tation of phosphate phases (Wellman et al. 2006).  Precipitation of phosphate minerals occurs when 
phosphate compounds degrade in water, due to hydrolysis, to yield the orthophosphate molecule (PO43-).  
The longer the polyphosphate chain, the slower the hydrolysis reaction that leads to orthophosphate 
production.  Accordingly, use of a long-chain polyphosphate compound does not result in a drastic 
change in hydraulic conductivity of the target aquifer. 
 Injection of a sodium tripolyphosphate amendment into the uranium-bearing saturated porous media 
has been shown to immobilize uranium through the formation of an insoluble uranyl phosphate mineral, 
autunite {X1-2[(UO2)(PO4)]2-1•nH2O}, where X is any monovalent or divalent cation.  Because autunite 
sequesters uranium in the oxidized form, U6+, rather than forcing reduction to U4+, the possibility of 
re-oxidation and subsequent re-mobilization of uranium is negated.  Release of uranium from the autunite 
structure may only occur through dissolution of the autunite structure.  Extensive testing demonstrates the 
very low solubility and slow dissolution kinetics of autunite under conditions relevant to the Hanford 
subsurface (Wellman et al. 2006).  In addition to autunite, excess phosphorous may result in apatite 
mineral formation, providing a long-term source of treatment capacity. 
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 2.5 Selection of the Treatability Test Site  
 Well 399-1-23 (Well ID C5000) has been selected as the candidate well for performing the 
treatability test (Figure 2).  This well is located at the southern end of a liquid waste disposal trench that is 
a known source for uranium.  The well is sufficiently far inland from the river such that infiltration of 
river water during normal high discharge conditions does not reach the well, which if that occurred, 
would complicate interpretation of test results.  This well was also selected because of its contaminant 
profile, i.e., it has a moderately thick (~6.1 m [20 ft]) interval of contaminated permeable Hanford gravel 
below the water table which will not be impacted significantly by river level fluctuations.  Depth-discrete 
uranium concentrations in groundwater samples collected during drilling in this well ranged up to 
202 μg/L in the uppermost portion of the aquifer and drop off to below detection deep in the aquifer 
below the Hanford/Ringold contact.  Hydraulic conductivity values also vary greatly above and below the 
contact as defined by depth discrete slug tests conducted as the borehole was advanced.  Values above the 
contact in the saturated Hanford formation are around 60 m (200 ft) per day and values in the Ringold are 
less then 5 m (16 ft) per day.  These data suggest that most of the dissolved uranium moves through the 
permeable interval above the Hanford/Ringold contact.  Hydrogeologic interpretations of the continuous 
sediment core reinforce this interpretation.  There is also a strong indication that the deep vadose interval 
just above the water table is contaminated with low levels of process uranium which maybe contributing 
to groundwater contamination levels.  These characterization results are plotted on the composite log for 
well 399-1-23 (Figure 3). 
 
3.0 Scope 
 This site characterization plan covers work elements associated with site-specific characterization of 
the polyphosphate treatability test site.  A schedule showing the timing of these work elements in relation 
to bench scale testing and planning/implementation of the polyphosphate injection test is provided in 
Figure 4.  Planned activities include (1) monitoring well installation, (2) site setup, (3) collection of 
baseline groundwater chemistry samples, (4) hydraulic testing to obtain formation hydraulic properties, 
(5) EBF testing to assess the vertical distribution of horizontal hydraulic conductivity (i.e., vertical 
heterogeneities), and (6) a conservative tracer injection test.  The tracer test will be used to further 
evaluate formation heterogeneities, to assess the downgradient transport of the tracer plume (i.e., aquifer 
transport properties), to refine the polyphosphate injection design, and to test operational procedures.  All 
characterization activities will be conducted in accordance with applicable Pacific Northwest National 
Laboratory (PNNL) procedures (PNL-MA-567; PNNL 1994) and any investigation derived waste will be 
handled in accordance with Hanford Site requirements. 
3.1 Well Installation 
 Five to eight monitoring wells will be installed within the 300-FF-5 Operable Unit, near  well 399-1-
23, which is located in the southeastern portion of the Hanford Site (Figures 1 and 2).  Up to five of the 
monitoring wells will be installed for operational monitoring (i.e., to monitor the initial injection pore 
volume of tracer, and ultimately, the polyphosphate solution) and will be installed within a radial distance 
of 9.1 m (30 ft) from the selected treatability test injection well (399-1-23).  Up to three additional 
monitoring wells will be installed farther downgradient of the test site to monitor downgradient transport  
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Figure 2.  Polyphosphate Treatability Test Site Location, 300-FF-5 Operable Unit, 300 Area 
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Figure 3.  Composite Log for LFI Well 399-1-23 
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Activity Name
Start 
Date
Finish 
Date May Jun Jul Aug Sept Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec Jan Feb Mar Apr May
2006 2007 2008
May Jun Jul Aug Sept Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec Jan Feb Mar Apr May
Polyphosphate Treatability  Test
Project Planning 6/14/06 5/29/07
Bench Scale Testing
Experimental Plan Preparation 6/14/06 7/4/06
Polyphosphate Hydrolysis Experiments 6/14/06 10/27/06
Autunite and Apatite Formation
Batch studies (rate & quantity) 6/14/06 9/29/06
Column Studies (rate, dist., trt. capacity) 8/2/06 1/30/07
Emplacement Efficiency 12/1/06 5/30/07
Immobilization of Uranium via Apatite
Batch studies (Kd adsorption & retention) 6/14/06 9/29/06
Column Studies (treatment  efficiency) 7/17/06 12/13/06
Apatite Barrier Longevity 1/1/07 7/2/07
Polyphosphate Phys.  Property Optimization 1/1/07 7/2/07
Interim Report on Bench Scale Testing 6/30/07
Pilot Scale Field Testing
Drilling Planning 6/14/06 8/30/06
Char. Plan (drilling, hyd & tracer testing) 6/14/06 8/30/06
Collect Site Specific Char. data
Monitoring Well Installation 8/30/06 10/16/06
Hydraulic / Tracer Testing 10/2/06 12/1/06
Test Systems Design and Setup 11/15/06 6/26/07
Injection Design Analysis 8/2/06 6/19/07
Field Test Plan Preparation 2/14/07 5/29/07
Polyphosphate Injection Test 7/4/07 8/28/07
Performance Assessment Sampling
Post treatment core sample collection 10/3/07 11/30/07
PA Core Sample Analysis 11/21/07 1/29/08
PA Groundwater Analysis 10/3/07 1/29/08
Post-treatment Hydraulic Testing 10/3/07 11/14/07
Data Analysis and Reporting 6/5/07 5/26/08
Final Report 5/25/08
 
Figure 4.  Polyphosphate Treatability Test Project Schedule 
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of the polyphosphate reagent and assess downgradient performance of the amendment.  Because  
insufficient bench-scale development work has been completed to determine appropriate downgradient 
well locations, these wells will be installed during a second drilling campaign, which will occur once 
initial site characterization activities have been completed and preliminary bench-scale results are 
available. 
 Based on the current conceptual understanding of the test site location and available budget for 
well installation, operational monitoring wells will consist of a two wells monitoring discrete intervals of 
the aquifer, one over the top portion and one over the bottom portion of the aquifer, and the other three 
wells monitoring the full 6.1 m (20 ft) of saturated aquifer thickness.  The proposed well layout is shown 
in Figure 5. 
 
 
 
 
Figure 5.  Polyphosphate Treatability Test Site Well Layout 
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 Due to extensive depth-discrete characterization that was conducted during the installation of well 
399-1-23, only limited additional characterization will be conducted as these boreholes are advanced.  At 
a minimum, a detailed lithologic description will be provided by the well site geologist from ground 
surface to total depth.  This description will include (1) drilling conditions and changes in drilling 
conditions (e.g., drilling method, drill rate, addition of fluids, heaving sand); (2) depths and types of all 
collected samples; (3) lithologic descriptions of sediments, including relative moisture; (4) results of 
radiation and chemical monitoring of sediments; and (5) water level. 
 If the collection of sediment grab samples does not significantly impact overall well installation cost, 
samples may be collected as required to support bench-scale testing.  Sediment grab samples would be 
collected over depth intervals of interest and at changes in lithology or at depths where unusual conditions 
are encountered (as determined by the field geologist).  Samples would be collected in pint or quart glass 
jars capable of sealing existing moisture in the sample for a reasonable time period.  If representative 
samples cannot be collected (e.g., if large particles do not fit in the container), notes describing the 
condition of the sample will be put in the geologist’s log.  All sediment samples that are collected will be 
labeled (well number and depth), and (if appropriate) radiation released.  Chip tray samples will be 
collected at regular intervals, with additional samples as required to adequately characterized changes in 
lithology, over the full depth interval of the borehole. 
 
 As with sediment sampling, geophysical logging will only be conducted if it does not significantly 
impact overall well installation cost.  Subsurface spectral gamma geophysical logging may be conducted 
based on contractor availability and the potential for impact to the drilling schedule.  Geophysical logging 
would be conducted by others over the total drill depth for identification of contaminants, site characteri-
zation, stratigraphic correlation, and selection of final screen placement.  Anomalous or unusual readings 
may be re-logged as necessary. 
 Well casings and screens will be composed of either PVC or stainless steel.  Well screens will consist 
of V-wire continuous wire wrap screen to prevent clogging.  All casing and screen material will be either 
5- or 10-cm (2- or 4-in.) nominal diameter.  Monitoring well screens will be 20-slot and the filter pack 
composed of 10- to 20-mesh silica sand.  Bentonite well seals will be completed in such a manner as to 
isolate the seal from leaking or migrating into the screen interval.  Fluor Hanford, Inc. shall determine the 
placement depths (at the direction of PNNL) and type of sealing materials to be used during the 
construction.  The well construction shall meet the WAC 173-160 requirements. 
3.2 Site Setup 
 This section includes a description of the site utilities, monitoring equipment, analytical equipment, 
injection equipment, and the integration of these components into the operational systems required to 
conduct the work elements included in this characterization plan.  PNNL will work with Fluor Hanford, 
Inc. to arrange for access to available site utilities.  PNNL will provide all operational and monitoring 
equipment required to conduct the work elements included in this characterization plan. 
17 
  
3.2.1 Site Utilities 
 Site utility requirements for these work elements includes access to electrical power, water supply, 
and wastewater disposal. 
3.2.1.1 Water Supply 
 To conduct the tracer injection test, and potentially a constant rate injection test to better quantify 
hydraulic properties, a substantial source of water is needed to make up the injection solutions.  It is 
estimated that the tracer injection test will require up to 38,000 L (100,000 gal) of water at rates as high as 
760 L/m (200 gpm).  If a pressurized raw or potable water supply is not available onsite, groundwater 
could be withdrawn from wells prior to the test and stored in onsite storage tanks until the injection tests 
are conducted.  Alternatively, a nearby uncontaminated well could be used to supply injection on demand, 
eliminating the need for the storage of large volumes of groundwater.  If available, a nearby fire hydrant 
or other pressurized water source could be utilized.  Static pressure at the point of connection should be 
~60 psi.  In the event that no water quality assessments have been performed on an available water source 
and they are deemed necessary, water samples will be submitted for anions, trace metals, and residual 
chlorine analysis.  This option would have to be evaluated to assure that injection water characteristics 
will not significantly impact aquifer geochemistry such that performance assessment of the technology is 
compromised. 
 
3.2.1.2 Electrical Service 
 Electrical power is required to operate site facilities, including a mobile laboratory and associated 
analytical equipment and injection/monitoring equipment.  Site power can be supplied by appropriately 
sized generators; however, line power is preferable because, once installed, it is virtually maintenance 
free and more reliable than generators. 
3.2.1.3 Wastewater Disposal 
 PNNL will work with Fluor Hanford, Inc. to arrange for the transport and appropriate disposal of all 
investigation derived waste. 
3.2.2 Monitoring Equipment 
3.2.2.1 Sampling Pumps 
 Dedicated Grundfos RediFlo2 sampling pumps or comparable will be installed in all site monitoring 
wells.  The sample tubing from each of these sampling pumps will be routed inside an onsite mobile 
laboratory and connected directly to a sampling manifold.  In the event RediFlo2 pumps are used, sample 
pumps will be operated using a manufacturer-supplied variable-speed control box (converts standard 
110-V single-phase power into three-phase power to meet the requirements of RediFlo2 sampling pumps) 
and a project-developed multichannel interface (pump switch box) that allows multiple sample pumps to 
be operated using a single control box.  If a different type of sampling pump is used, a comparable 
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multichannel switchbox will be developed to facilitate efficient high frequency sampling of multiple 
monitoring wells. 
3.2.2.2 Sampling Manifold 
 A sampling manifold will be used that allows all sampling streams to be routed into a central flow 
cell for monitoring field parameters and sampling port for the collecting groundwater samples.  The 
advantage of this type of system is that all field parameter measurements are made using a single set of 
electrodes, which improves data quality and comparability of spatially distributed measurements.  
Consistent labeling between the sampling manifold and pump switch box simplifies selection of the well 
to be sampled and reduces the chance of operator error during the frequent sampling associated with the 
injection tests. 
3.2.2.3 Field Parameter Measurements 
 Field parameters will be monitored using pH, oxidation-reduction potential (ORP), temperature, 
specific conductance (SpC), and dissolved oxygen (DO) electrodes installed in a flow-through monitoring 
assembly.  The flow-through assembly has been designed to minimize the amount of “dead space” within 
the monitoring chamber and results in flow-through residence times of less than three seconds under 
standard monitoring conditions.  Purge volumes pumped prior to sample collection will be determined by 
monitoring stabilization of field parameters.  The field parameter monitoring electrodes that will be used 
during this field test will meet the specifications shown in Section 4. 
 
3.2.2.4 Water-Level/Pressure Response Measurements 
 Pressure transducers (10 and 20 psi, 0.1% of full-scale accuracy) will be installed in selected wells to 
monitor pressure response during hydraulic and tracer injection tests and continuously recorded using a 
Campbell Scientific CR10 datalogger, or comparable.  Transducer readings will be validated periodically 
with water-level measurements to check for transducer drift.  Water levels will be measured using a high-
accuracy, National Institute of Standards and Technology traceable, non-stretch, metal-taped, water-level 
meter marked in 0.03.04-cm (0.01-ft) gradations. 
3.2.3 Injection and Withdrawal Equipment 
3.2.3.1 Injection Manifold 
 The injection manifold consists of an injection pump and appropriately routed piping, valving, and 
flow rate monitoring equipment.  The manifold is used to control (both rate and concentration), monitor, 
and sample the injection solutions.  The manifold will be constructed of 316 stainless steel and will use 
stainless steel ball valves for both diversion/shutoff and flow control valves. 
3.2.3.2 Injection Pump 
 A 0.75 horse power (hp) Grundfos stainless steel multi-stage centrifugal pump (Model # CRN2-30) or 
comparable will be used for injecting the concentrated solution.  The injection tubing that extends from 
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the well head to the center of the injection interval will be constructed of appropriately sized stainless 
steel or PVC pipe. 
3.2.3.3 Turbine Flow-Meters 
 Omega turbine flow meters will used to measure the flow rate of the various streams and the total 
injection flow rate.  Depending on the design injection rate, either a 2.5- or 5.0-cm (1- or 2-in.) diameter 
flow meter will be used to monitor the dilution water and total injection rate and a 2.5-cm (1-in.) diameter 
flow meter will be used to monitor the injection rate of the concentrated reagent solutions.  These flow 
meters will be continually logged with a Campbell Scientific CR10 datalogger. 
3.2.3.4 Submersible Extraction Pump 
 An appropriately sized stainless steel submersible will be used as the extraction pump if groundwater 
is used as the water supply.  The extraction pump will be installed on an appropriately sized stainless steel 
riser. 
3.2.4 Description of Equipment Integration/Operation  
 Following is a description of how the various equipment components are integrated into the systems 
required to conduct the tracer injection test (and any constant rate injection testing, if required) and collect 
groundwater samples from the polyphosphate treatability test site. 
3.2.4.1 Injection Testing 
 All injection testing will be conducted using the equipment described above.  The desired injection 
concentration will be achieved by mixing the concentrated tracer solutions with dilution water from the 
pressurized source.  Injection pressure for the concentrated solutions and dilution water will be provided 
by the stainless steel injection pump and the pressurized water supply (e.g., fire hydrant or downhole 
extraction pump), respectively.  The two injection streams will be mixed within the injection manifold 
before the solution arrives at the point of injection (i.e., the center of the injection well’s screen interval). 
 All injection flow rates (concentrated solution, dilution water, total) will monitored with turbine flow 
meters and controlled by manually adjusting flow control valves.  Sample ports will be located on the 
manifold so that samples of the concentrated and injection solutions can be collected throughout the 
injection test. 
3.2.4.2 Groundwater Sample Collection 
 Groundwater sample collection will be conducted using the equipment described above.  The ground-
water sampling equipment consists of dedicated variable-speed submersible sampling pumps installed in 
all site monitoring wells with sample tubing and control wiring routed to a central location inside the 
onsite mobile laboratory where groundwater field parameters are monitored (in a flow-through cell) and 
groundwater samples are collected. 
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 The procedure for monitoring field parameters and collecting groundwater samples using this 
equipment is described below: 
1. Select well to be sampled on pump switch box and sampling manifold. 
2. Start pump at predetermined purge rate (~4 to 12 L [1 to 3 gal] per minute). 
3. Following displacement of any air bubbles trapped in the sample tubing (generally within the first 
20 to 30 seconds), divert ~ 2 to 4 L (0.5 to 1 gal) per minute of sample stream to flow-through cell. 
4. Monitor field parameters until they have stabilized. 
5. Record field parameter measurements in field log book or project-specific data sheets  and collect 
required groundwater samples. 
6. Select next well to be sampled and repeat process. 
3.3 Baseline Groundwater Chemistry  
 From two to three sets of groundwater chemistry samples will be collected from site monitoring wells 
and submitted for analysis to establish baseline conditions, prior to the tracer test and emplacement of the 
polyphosphate amended treatment zone.  Sampling and analytical equipment used for this activity will be 
capable of measuring the specific analytes indicated in Section 4, Table 1. 
3.4 Hydraulic Testing 
 Hydraulic tests will be conducted in the injection well and monitoring wells, as required, to determine 
the hydraulic properties of the aquifer and the specific capacity of the injection well.  Due to investigation 
derived waste disposal limitations, this initial hydraulic testing will be limited to a step injection test to 
determine the specific capacity of the injection well and either slug interference testing or a short duration 
constant-rate injection test to provide a semi-quantitative estimate of hydraulic properties.  Pressure 
recovery data from the tracer injection test may also be analyzed if the slug interference test and/or short 
duration constant-rate injection test does not provide sufficient data for a good quantitative estimate of 
hydraulic properties.  These test data will be representative of baseline (pre-injection) aquifer conditions  
and will be incorporated into the design analysis of the pilot technology demonstration.  Hydrologic test 
data will be analyzed using peer reviewed analytical or numerical methods that are applicable to the given 
test conditions. 
 In addition to these standard aquifer testing methods, electromagnetic borehole flowmeter tests may 
be conducted to assess the vertical distribution of horizontal hydraulic conductivity.  Although one test 
was conducted in well 399-1-23 immediately following the LFI drilling activities, additional testing may 
be conducted in the newly installed monitoring wells to evaluate the spatial distribution of vertical 
variability. 
21 
  
3.5 Tracer Injection Test 
 The objective of the tracer test is to further evaluate formation heterogeneities, to assess the down-
gradient transport of the tracer plume (i.e., aquifer transport properties), to refine the polyphosphate 
injection design, and to test operational procedures.  This tracer test will provide information on the 
effective porosity of the aquifer at the treatability test site  and arrival times at the monitoring wells.  The 
effective porosity will help determine the volumes of polyphosphate solution required.  The arrival curves 
will help design the sampling frequency needed for each monitoring well for the polyphosphate injection 
test.  An additional benefit of the tracer test is to help test equipment operation and procedures needed for 
the polyphosphate injection test. 
 A solution containing the conservative tracer, potassium or sodium bromide (~80 ppm Br-), will be 
prepared and injected into the central injection well shown on Figure 5.  A tracer volume will be used that 
assures arrival at all operational monitoring wells.  Bromide concentrations will be measured in the 
surrounding monitoring wells and breakthrough curves (time vs. concentration) will be prepared for each 
well.  The volume of tracer solution required, which will be similar to the nominal injection planned for 
the polyphosphate injection test, will depend on the targeted treatment zone thickness and planned radial 
extent.    
 Bromide concentrations will be measured using ion-specific electrodes at the field site.  Archive 
samples will also be collected and submitted to PNNL laboratories for verification by ion chromato-
graphy.  A detailed discussion of analytical requirements is provided in Section 4. 
4.0 Sampling and Analysis 
 Groundwater sampling will be conducted during site-specific characterization of the polyphosphate 
treatability test site.  All sampling will be conducted in accordance with applicable PNNL procedures 
(PNL-MA-567; PNNL 1994) and the following sampling and analysis requirements.  Investigation 
derived waste will be handled in accordance with Hanford Site requirements. 
 As indicated in Section 3, groundwater samples will be collected and submitted for laboratory 
analysis during two of the planned work elements:  baseline groundwater chemistry sampling and 
aqueous sample collection during and following the tracer injection test.  During both types of sampling, 
field parameters (pH, SpC, DO, ORP, and T) will be measured and recorded manually on data sheets 
which will be copied for distribution.  Calibration of field probes will follow the manufacturer’s 
instructions and applicable PNNL procedures (PNL-MA-567) using standard calibration solutions.  
Detailed sampling instructions, including which wells to sample and at what frequency, will be posted in 
the field laboratory prior to initiation of the test. 
 Sample collection requirements for baseline groundwater chemistry determination and observational 
monitoring for the tracer injection test are provided in Table 1 and Table 2, respectively.  During baseline 
sampling, all available test site monitoring wells will be sampled to determine baseline conditions.  
During the tracer injection test, samples will be collected with sufficient frequency to adequately describe 
tracer arrivals curves at the various operational monitoring points.  All analyses will be performed in 
accordance with the guidelines set forth in Table 3. 
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Table 1.  Baseline Groundwater Chemistry Sampling Requirements 
Parameter 
Media/ 
Matrix Sampling Frequency 
Volume/ 
Container Preservation 
Holding 
Time 
Major Cations: 
Al, As, B, Ba, Bi, Ca, 
Co, Fe, K, Mg, Mn, Ni, 
Zn, Zr, P, Sr, Na, Si, S, 
Sb 
Water Two to three baseline 
sampling events  
20-ml plastic 
vial 
Filtered, 
HNO3 to pH <2 
60 Days 
RCRA/Trace Metals: 
Cr, Cu, As, Se, Mo, Ag, 
Cd, Pb, 238U 
Water Two to three baseline 
sampling events 
20-ml plastic 
vial 
Filtered, 
HNO3 to pH <2 
60 Days 
Anions:  Cl-, Br- , SO42-, 
PO43-, NO2-, NO3-
Water Two to three baseline 
sampling events 
20-ml plastic 
vial 
Cool 4°C 45 Days 
pH Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
Specific Conductance Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
Dissolved Oxygen  Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
Oxidation-Reduction 
Potential  
Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
Temperature Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
N/A = Not applicable. 
 
Table 2.  Tracer Injection Test Sampling Requirements 
Parameter 
Media/ 
Matrix Sampling Frequency 
Volume/ 
Container Preservation 
Holding 
Time 
Anions:  Br- Water Determined based on 
predicted tracer arrivals 
20-ml plastic 
vial 
Cool 4°C 45 Days 
Br- Field Screening Water Determined based on 
predicted tracer arrivals 
Field 
Measurement 
None N/A 
pH Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
Specific Conductance Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
Dissolved oxygen  Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
Oxidation-Reduction 
Potential  
Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
Temperature Water Monitored during each 
sampling event 
Field 
Measurement 
None N/A 
N/A = Not applicable. 
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Table 3.  Analytical Requirements 
Parameter Analysis Method 
Detection Limit  or 
(Range) 
Typical Precision/ 
Accuracy QC Requirements 
Major Cations/Metals:   
Ca, Fe, K, Mg, P, Na, Si, 
S 
Al, B, Ba, Bi, Ni, Zn, Zr, 
Sr 
ICP-OES, PNNL-
AGG-ICP-AES 
(similar to EPA 
Method 6010B) 
 
1 mg/L 
 
0.1 mg/L 
±10% Daily calibration; blanks 
and duplicates and 
matrix spikes at 10% 
level per batch of 20. 
RCRA / Trace Metals: 
Cr, Cu, As, Se, Mo, Ag, 
Cd, Pb, 238U 
ICP-MS, PNNL-
AGG-415 (similar 
to EPA Method 
6020) 
1 μg/L for trace 
elements 
±10% Daily calibration; blanks 
and duplicates and 
matrix spikes at 10% 
level per batch of 20. 
Anions:  Cl-, Br-, SO42-, 
PO43-, NO2-, NO3-
Ion Chromato-
graphy, AGG-IC-
001 (based on EPA 
Method 300.0A) 
1 mg/L ±15% Daily calibration; blanks 
and duplicates at 10% 
level per batch of 20. 
Br- Field screening Ion selective 
electrode 
(0.4 to 79,900 mg/L) For indication only Follow manufacturer 
recommendations 
pH pH electrode (2 to 12 units) ±0.2 pH unit User calibrate, follow 
manufacturer 
recommendations 
Specific conductance Electrode (0 to 100 mS/cm) ±1% of reading User calibrate, follow 
manufacturer 
recommendations 
Dissolved oxygen Membrane 
electrode 
(0 to 20 mg/L) ±0.2 mg/L User calibrate, follow 
manufacturer 
recommendations 
Oxidation-Reduction 
Potential 
Electrode (-999 to 999 mV) ±20 mV User calibrate, follow 
manufacturer 
recommendations 
Temperature Thermocouple (-5 to 50°C) ±0.2°C Factory calibration 
ICP = Inductively coupled plasma. 
OES = Optical emission spectrometry. 
MS = Mass spectrometry. 
 
 
5.0 Data Recording/Management/Reporting 
 Drilling, well completion, and sampling activities shall be recorded on the applicable procedural 
forms or logbooks and maintained in the field files by Fluor Hanford, Inc. (drilling and well completion) 
and PNNL project personnel.  Upon completion of all activities, the field file custodian shall transmit a 
copy of all well drilling, completion, development, and sampling documentation to PNNL for inclusion in 
the project files. 
 For the hydraulic and tracer injection testing, a project-specific database will be developed and 
maintained to collect, organize, store, verify/validate, and manage analytical laboratory data and/or field 
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measurements for collected samples.  The data will be stored electronically in Microsoft Excel 
spreadsheets and paper copies will be maintained in the project files. 
 Data collected during these site characterization activities will be reported in a milestone report 
documenting results of the polyphosphate treatability test.  The final report will cover activities ranging 
from basic laboratory development work through the field-scale demonstration of the technology.  
Findings presented in the final report will form the basis for an evaluation of this technology for full-scale 
implementation during the 300-FF-5 feasibility study. 
 
 
6.0 Health and Safety Training Requirements 
 All personnel working within site control zones must comply with the Occupational Safety and 
Health Administration (OSHA) regulations as defined in 29 CFR 1910.  In addition to other requirements, 
these regulations require all onsite personnel to receive a minimum of 40 hours training in health and 
safety for hazardous waste operations.  In addition, the same personnel must be enrolled in a yearly 
medical surveillance program that includes a medical examination and work history review with special 
emphasis on symptoms related to the handling of hazardous substances and the fitness for duty.  
Personnel shall be certified as medically qualified to perform hazardous field activities or equivalent.  
Field personnel must successfully pass an annual respirator fit test, conducted in accordance with OSHA 
regulations, for the respiratory device(s) they will use.  Supervisors must have received first aid/CPR 
training and attended the 8-hour supervisor’s course.  Additional relevant health and safety requirements 
specified in the drilling specific site health and safety plan developed by Fluor Hanford, Inc. will also be 
followed by PNNL project personnel when on site. 
 
 All pre-drilling planning, waste management, purgewater management, health and safety, and overall 
risk management will be the responsibility of Fluor Hanford, Inc., DOE’s drilling contractor.  All drill site 
activities will be managed by Fluor Hanford, Inc. with technical oversight provided by PNNL. 
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